Ligand validation:4EW9

ADA: alpha-D-galactopyranuronic acid

ADA is a Ligand Of Interest in 4EW9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EW9_ADA_A_211	48%	34%	0.185	0.927	1.37	1.22	2	2	0	0	100%	1
4YZA_ADA_B_211	100%	33%	0.033	0.991	1.12	1.53	-	2	0	0	92%	0.2677
4YZX_ADA_B_214	100%	55%	0.036	0.991	0.99	0.77	1	-	0	0	92%	0.2492
4YZ0_ADA_B_210	99%	24%	0.048	0.98	1.48	1.63	3	5	1	0	100%	0.43
4Z03_ADA_A_210	98%	39%	0.047	0.983	1.21	1.16	-	1	0	0	92%	0.2492
4YZQ_ADA_B_212	96%	1%	0.061	0.982	6.64	1.55	8	3	0	0	92%	0.36
4Z06_ADA_B_205	96%	24%	0.063	0.969	1.8	1.34	3	2	0	0	100%	0.93

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.